Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

NCSP reports for 9 months of 2024 by RAS

10/24/24 NMTP

LSR reported for 9 months of 2024 by RAS

10/24/24 LSRG

LESK reported for 9 months of 2024 by RAS

10/24/24 LPSB

Central Telegraph reported for 9 months of 2024 by RAS

10/24/24 CNTL

Himprom reported for 9 months of 2024 by RAS

10/24/24 HIMCP

TCS Holding disclosed the first results of the group, including T-Bank and Rosbank

10/24/24 TCSG

Fix Price will build distribution center in Kazan

10/24/24 FIXP

MD Medical opened a clinic in Chelyabinsk

10/24/24 MDMG

Henderson's sales for 9 months increased by 13.4%

10/24/24 HNFG

Astrakhanenergosbyt reported for 9 months of 2024 by RAS

10/24/24 ASSB